Journey Medical Corporation (NASDAQ:DERM) concluded the trading at $5.18 on Thursday, January 13 with a fall of -3.90% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $5.39 with its price kept floating in the range of $5.01 and $5.42 on the day. Considering stock’s 52-week price range provides that DERM hit a high price of $10.20 and saw its price falling to a low level of $4.46 during that period. Over a period of past 1-month, stock came subtracting -23.26% in its value.
With its current market valuation of $80.13 million. Analysts are in estimates of -$0.29 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -$2.38 for 2021 with estimates of that growing to -$0.92 in next year.
Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of $20.73 million. They suggested that in the process company could generate revenue of as low as $20.4 million which could climb up to $21.06 million to hit a high.
In last 7 days, analysts came adjusting their opinions about stock’s EPS with no upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement.
According to ratings assigned by 2 analysts at the scale of 1 to 5 with 1.00 representing a strong buy and 5.00 suggesting a strong sell; 0 of them are recommending Journey Medical Corporation (DERM) as a Hold, while 2 are in view that stock is a Buy. Recommendation by 0 analysts for the stock is an Underweight while number of those analysts who rated the stock as an Overweight is 0, whereas 0 of them are considering the stock as a Sell. When taken as whole, stock gets a rating of Overweight and that encourages the investors to exploit the opportunity and build their stake up in the company.
Digging deeper we become aware of the PEG ratio of the DERM stock which is currently positioned at 0. It further provides that stock’s current price level is -9.25% away from its 20-day simple moving average and is -24.28% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 35.69 while volatility remained at 12.41% over the past week which changes to 8.25% when measuring it over the past month. Average true range or ATR is currently at 0.52. In predicting price targets of as low as $14.00 and as high as $17.00, analysts are in agreement on assigning the stock over the next 12 months average price target of $15.50. Stock’s current price level is -170.27% above from estimated low price target while it is -228.19% below the estimated high; and even if the DERM’s share succeeded to reach the median price of $15.50, then the outlook of -199.23% could come to the excitement of the investors.
Having a second look at Journey Medical Corporation (NASDAQ:DERM) provides that stock’s average daily trading volume for 3 months was 194.70K. Number of outstanding shares of the stock stood at 15.47 million.
The percentage of outstanding shares held by the insiders is 10.80% while it is 0.10% for the institutional holders. Subtraction of -3.72% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.